Skip to main content
Our Work

Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products: A Workshop Series

Completed

This workshop series provided a venue for stakeholders to discuss structured approaches to characterize and communicate the sources of uncertainty in benefit-risk assessment in drug development and their implications on pharmaceutical regulatory decisions. The workshop was hosted by the National Academies Forum on Drug Discovery, Development and Translation.

Please visit our event pages for additional information and meeting materials for the workshop (held on February 12 and May 12, 2014).

Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.